You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TRIHEXYPHENIDYL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trihexyphenidyl Hydrochloride, and when can generic versions of Trihexyphenidyl Hydrochloride launch?

Trihexyphenidyl Hydrochloride is a drug marketed by Mikart, Pharm Assoc, Pharm Ventures, Hikma, Natco Pharma Ltd, Novitium Pharma, Nylos, Vangard, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in TRIHEXYPHENIDYL HYDROCHLORIDE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trihexyphenidyl Hydrochloride

A generic version of TRIHEXYPHENIDYL HYDROCHLORIDE was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIHEXYPHENIDYL HYDROCHLORIDE?
  • What are the global sales for TRIHEXYPHENIDYL HYDROCHLORIDE?
  • What is Average Wholesale Price for TRIHEXYPHENIDYL HYDROCHLORIDE?
Drug patent expirations by year for TRIHEXYPHENIDYL HYDROCHLORIDE
Recent Clinical Trials for TRIHEXYPHENIDYL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Taiwan University HospitalPhase 4
University of Florida
Bachmann Strauss Dystonia & Parkinson Foundation, Inc.

See all TRIHEXYPHENIDYL HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for TRIHEXYPHENIDYL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRIHEXYPHENIDYL HYDROCHLORIDE

US Patents and Regulatory Information for TRIHEXYPHENIDYL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride ELIXIR;ORAL 040251-001 Sep 27, 1999 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Ltd TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 091630-002 Nov 17, 2010 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 040337-002 Feb 16, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 040184-001 Feb 6, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.